Silo Pharma, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $356.5K | — | $-39.4K | $-49.8K |
| Depreciation & Amortization | — | — | — | — |
| Depreciation | — | — | — | — |
| Amortization | — | — | — | — |
| Stock-Based Compensation | $177.5K | — | — | $0 |
| Net Cash from Operating Activities | $-284.6K | $-181.6K | $-21.5K | $-46.3K |
| Investing Activities | ||||
| Capital Expenditures | — | — | — | — |
| Business Acquisitions | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — |
| Financing Activities | ||||
| Dividends Paid | — | — | — | — |
| Stock Repurchases | — | — | — | — |
| Net Cash from Financing Activities | — | $2.2M | $20.0K | $575 |
| Net Change in Cash | $-284.6K | $2.0M | $-1.5K | $-45.7K |
| Free Cash Flow | — | — | — | — |